Komori
Business alliance9987SUZUKEN CO.,LTD.Trading & Wholesale

Execution of a basic agreement aimed at further deepening the strategic partnership with EPS Holdings Corporation and EP Pharma Line Co., Ltd.

Suzuken has entered into a basic agreement to discuss and consider the scope of future collaboration in order to further deepen its existing strategic partnership with EPSホールディングス株式会社 and 株式会社EPファーマライン. The parties will consider, by the end of March 2027, the joint development of new services combining the AI avatar “AI-MS” with a medical contact center, among other initiatives.

Worth reading
41Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Avoiding a definitive answer
How definitive the wording is.

Agreements reached under this partnership

Business alliance
9987SUZUKEN CO.,LTD.
Alliance partnerEPSホールディングス株式会社 / 株式会社EPファーマライン
Details of the alliance
  1. 1

    Enhancement of the sales and support structure through multiple channels, including AI-MS

  2. 2

    Further strengthening of back-office operations centered on medical contact center functions

  3. 3

    Potential collaboration aimed at medium- to long-term business growth through the use of the management resources of both groups, among other initiatives

These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.

About the partner
Business Description株式会社EPファーマライン is primarily engaged in the medical contact center business. Its medical contact center is a 24/365 call center specializing in pharmaceuticals, healthcare, medical devices and health care, and provides comprehensive support for a wide range of business processes in the medical and health care fields through BPO services.
LocationShinjuku-ku, Tokyo, and Toshima-ku, Tokyo
Impact on Business Performance

At present, this matter is not expected to affect the performance of the Suzuken Group.

Contract Date14 May 2026
Agreements reached under this partnership
ItemDetails
Name of alliance partnerEPSホールディングス株式会社, 株式会社EPファーマライン
Alliance partner's business activities株式会社EPファーマライン is primarily engaged in the medical contact center business. Its medical contact center is a 24/365 call center specializing in pharmaceuticals, healthcare, medical devices and health care, and provides comprehensive support for a wide range of business processes in the medical and health care fields through BPO services.
Alliance partner's locationShinjuku-ku, Tokyo, and Toshima-ku, Tokyo
Type of allianceBusiness alliance
Details of the allianceEnhancement of the sales and support structure through multiple channels, including AI-MS, Further strengthening of back-office operations centered on medical contact center functions, Potential collaboration aimed at medium- to long-term business growth through the use of the management resources of both groups, among other initiatives
Contract Date14 May 2026
Impact on Business PerformanceAt present, this matter is not expected to affect the performance of the Suzuken Group.
Items this document does not state (16)
Alliance partner's capitalAlliance partner's net salesAlliance partner's operating incomeNumber of shares acquiredAcquisition priceShareholding ratioOverview of the joint ventureOwnership ratioDispatch of directors and officersContract PeriodNumerical targets under the allianceShareholding PolicyDate of board resolutionAlliance start dateShare Acquisition Date and Payment DateChange in major shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The environment surrounding healthcare and pharmaceutical distribution is changing due to factors including labor shortages, increasingly sophisticated operations and the growing use of digital technology. Suzuken determined that it is necessary to enhance sales functions, strengthen back-office functions and establish a multichannel structure through the use of digital technology.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Execution of a basic agreement aimed at further deepening the strategic partnership with EPS Holdings Corporation and EP Pharma Line Co., Ltd. | SUZUKEN CO.,LTD. (9987) timely disclosure | Komori